Back to Results
First PageMeta Content
Medicine / Intersect ENT / Propel mometasone furoate implant / Sinus implant / Forward-looking statement / Sinusitis / Otorhinolaryngology / Sinus / Mometasone furoate


Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany Decision Represents Early Step in Building the Company’s Foundation Internationally MENLO PARK, Calif.—January 29, 2016—Intersect
Add to Reading List

Document Date: 2016-02-02 07:14:47


Open Document

File Size: 136,77 KB

Share Result on Facebook